Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

C3c Human

Complement Component C3c Human

Human C3c produced in Human Plasma having a molecular mass of 137 KDa. Complement C3c consists of three peptides: C3c Beta chain (23-667), C3c alpha chain fragment 1 (749-954) and C3c alpha chain fragment 2 (1321-1663) joined together by disulphide bonds.  
Shipped with Ice Packs
Cat. No.
BT16244
Source
Human Plasma.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

C3d Human

Complement C3d Human

Human Complement C3d produced in Human plasma having a molecular mass of 33.8kDa.

Shipped with Ice Packs
Cat. No.
BT16325
Source

Human Plasma.

Appearance

Sterile filtered solution.

C4 Human

Complement C4 Human

Human Complement C4 produced in Human plasma having a molecular mass of 205 kDa.

Shipped with Ice Packs
Cat. No.
BT16410
Source

Human Plasma.

Appearance

Sterile filtered solution.

C4a Human

Complement C4a Human

Human Complement C4a produced in Human plasma having a molecular mass of 8,759 Dalton.

Shipped with Ice Packs
Cat. No.
BT16470
Source

Human Plasma.

Appearance

Sterile filtered solution.

C4b Human

Complement C4b Human

Human Complement C4b produced in Human plasma is a glycosylated polypeptide chain containing 3 disulfide-linked chains and having a molecular mass of 195 kDa.

Shipped with Ice Packs
Cat. No.
BT16547
Source

Human Plasma.

Appearance

Sterile filtered solution.

C4BP Human

Complement Component 4 Binding Protein Human

C4BP Human produced in Human Plasma having a molecular mass of 540 kDa.

Shipped with Ice Packs
Cat. No.
BT16620
Source

Human Plasma.

Appearance

Sterile filtered solution.

C4BPB Human

Complement Component 4 Binding Protein, Beta Human Recombinant

C4BPB Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 260 amino acids (18-252 a.a) and having a molecular mass of 29kDa.
C4BPB is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT16696
Source
E.coli.
Appearance
Sterile Filtered colorless solution.

C4c Human

Complement Component C4c Human

Human C4c produced in Human plasma having a molecular mass of 210 kDa.
Shipped with Ice Packs
Cat. No.
BT16797
Source
Human Plasma.
Appearance
Sterile Filtered clear solution.

C5 Human

Complement C5 Human

Human Complement C5 produced in Human plasma having a molecular mass of 190 kDa.

Shipped with Ice Packs
Cat. No.
BT16901
Source

Human Plasma.

Appearance

Sterile filtered solution.

C5a Human

Complement Component C5a Human Recombinant

C5a Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 74 amino acids and having a molecular mass of 8.3kDa.
The Human C5a is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17103
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

The complement system is a crucial part of the immune system, consisting of over 20 proteins that circulate in the blood and tissue fluids. These proteins are typically inactive but become sequentially activated in response to the recognition of molecular components of microorganisms . The complement system can be classified into three main pathways: the classical pathway, the alternative pathway, and the lectin pathway .

Biological Properties

Complement components are serum proteins that cooperate with both the innate and adaptive immune systems to eliminate pathogens . They are primarily synthesized by liver cells, but also by macrophages and other cell types . These proteins are heat-labile and glycosylated . They are distributed in various tissues and are present in the sera of all mammals, including humans, birds, amphibians, and fishes .

Biological Functions

The primary functions of complement components include opsonization, chemotaxis, and lysis of pathogens . They play a significant role in immune responses by enhancing the ability of antibodies and phagocytic cells to clear microbes and damaged cells . Complement components also promote inflammation and attack the pathogen’s cell membrane .

Modes of Action

Complement activation occurs through three pathways: the classical pathway, the lectin pathway, and the alternative pathway . Each pathway involves a series of proteolytic cleavages that activate complement proteins, leading to the formation of enzyme complexes such as C3 and C5 convertases . These complexes facilitate the binding of complement proteins to pathogens, promoting their opsonization and lysis . The membrane attack complex (MAC) is formed, which creates pores in the pathogen’s membrane, leading to cell lysis .

Regulatory Mechanisms

The complement system is tightly regulated to prevent damage to host tissues . Regulatory proteins, such as complement control proteins, interact with complement components to distinguish between self and non-self cells . These regulatory mechanisms include transcriptional regulation and post-translational modifications that control the expression and activity of complement proteins .

Applications

Complement components have various applications in biomedical research, diagnostic tools, and therapeutic strategies . They are used to study immune responses and develop treatments for autoimmune diseases and infections . Complement proteins are also utilized in diagnostic assays to detect immune deficiencies and monitor disease progression .

Role in the Life Cycle

Throughout the life cycle, complement components play a vital role in maintaining immune homeostasis . They are involved in the clearance of apoptotic cells and immune complexes, which is essential for preventing autoimmune diseases . Complement activity is crucial from development to aging, as it helps protect against infections and supports tissue repair .

© Copyright 2024 Thebiotek. All Rights Reserved.